Yuag, Qiana Mae .

HRN: 29-27-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2026
CEFTAZIDIME 1GM (VIAL)
07/12/2026
07/19/2026
IVTT
160mg
Q12h
MAP, PSNB
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: